Aspirin/Methocarbamol

阿司匹林/美索巴莫

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Methocarbamol
Drug Alias Name阿司匹林美索巴莫Aspirin-Methocarbamol美索巴莫阿司匹林Methocarbamol-Aspirin美索巴莫/阿司匹林 +[9] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsCarbonic anhydrase I inhibitors
TargetsCarbonic anhydrase ICyclooxygenases
Therapy Area/IndicationsMusculoskeletal Pain
Global Approved IndicationsMusculoskeletal Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/04/15
Country/TerritoryUnited States
CombinationsYes MethocarbamolAspirin
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMusculoskeletal Pain
Inactive IndicationsN/A

Other Information

ATC CodeN02
Related LinksN/A